Report Detail
Global Antibody Drug Conjugate Market Insights and Forecast to 2026
- RnM4153330 |
- 24 August, 2020 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Antibody Drug Conjugate market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antibody Drug Conjugate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Antibody Drug Conjugate market is segmented into
Adcetris
Kadcyl
Other
Segment by Application, the Antibody Drug Conjugate market is segmented into
Hospital
Pharmaceutical Company
Research Institutions
Regional and Country-level Analysis
The Antibody Drug Conjugate market is analysed and market size information is provided by regions (countries).
The key regions covered in the Antibody Drug Conjugate market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Antibody Drug Conjugate Market Share Analysis
Antibody Drug Conjugate market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antibody Drug Conjugate business, the date to enter into the Antibody Drug Conjugate market, Antibody Drug Conjugate product introduction, recent developments, etc.
The major vendors covered:
Seattle Genetics/Takeda
Roche
ImmunoGen
Immunomedics
Pfizer
Celldex Therapeutics
Millennium Pharmaceuticals
Bayer HealthCare
Mersana Therapeutics
Heidelberg Pharma
Oxford BioTherapeutics
Takeda Pharmaceutical Company Limited
1 Study Coverage
- 1.1 Antibody Drug Conjugate Product Introduction
- 1.2 Market Segments
- 1.3 Key Antibody Drug Conjugate Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Antibody Drug Conjugate Market Size Growth Rate by Type
- 1.4.2 Adcetris
- 1.4.3 Kadcyl
- 1.4.4 Other
- 1.5 Market by Application
- 1.5.1 Global Antibody Drug Conjugate Market Size Growth Rate by Application
- 1.5.2 Hospital
- 1.5.3 Pharmaceutical Company
- 1.5.4 Research Institutions
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Antibody Drug Conjugate Market Size, Estimates and Forecasts
- 2.1.1 Global Antibody Drug Conjugate Revenue 2015-2026
- 2.1.2 Global Antibody Drug Conjugate Sales 2015-2026
- 2.2 Global Antibody Drug Conjugate, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Antibody Drug Conjugate Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Antibody Drug Conjugate Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Antibody Drug Conjugate Competitor Landscape by Players
- 3.1 Antibody Drug Conjugate Sales by Manufacturers
- 3.1.1 Antibody Drug Conjugate Sales by Manufacturers (2015-2020)
- 3.1.2 Antibody Drug Conjugate Sales Market Share by Manufacturers (2015-2020)
- 3.2 Antibody Drug Conjugate Revenue by Manufacturers
- 3.2.1 Antibody Drug Conjugate Revenue by Manufacturers (2015-2020)
- 3.2.2 Antibody Drug Conjugate Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Antibody Drug Conjugate Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Antibody Drug Conjugate Revenue in 2019
- 3.2.5 Global Antibody Drug Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Antibody Drug Conjugate Price by Manufacturers
- 3.4 Antibody Drug Conjugate Manufacturing Base Distribution, Product Types
- 3.4.1 Antibody Drug Conjugate Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Antibody Drug Conjugate Product Type
- 3.4.3 Date of International Manufacturers Enter into Antibody Drug Conjugate Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Antibody Drug Conjugate Market Size by Type (2015-2020)
- 4.1.1 Global Antibody Drug Conjugate Sales by Type (2015-2020)
- 4.1.2 Global Antibody Drug Conjugate Revenue by Type (2015-2020)
- 4.1.3 Antibody Drug Conjugate Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Antibody Drug Conjugate Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Antibody Drug Conjugate Sales Forecast by Type (2021-2026)
- 4.2.2 Global Antibody Drug Conjugate Revenue Forecast by Type (2021-2026)
- 4.2.3 Antibody Drug Conjugate Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Antibody Drug Conjugate Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Antibody Drug Conjugate Market Size by Application (2015-2020)
- 5.1.1 Global Antibody Drug Conjugate Sales by Application (2015-2020)
- 5.1.2 Global Antibody Drug Conjugate Revenue by Application (2015-2020)
- 5.1.3 Antibody Drug Conjugate Price by Application (2015-2020)
- 5.2 Antibody Drug Conjugate Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Antibody Drug Conjugate Sales Forecast by Application (2021-2026)
- 5.2.2 Global Antibody Drug Conjugate Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Antibody Drug Conjugate Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Antibody Drug Conjugate by Country
- 6.1.1 North America Antibody Drug Conjugate Sales by Country
- 6.1.2 North America Antibody Drug Conjugate Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Antibody Drug Conjugate Market Facts & Figures by Type
- 6.3 North America Antibody Drug Conjugate Market Facts & Figures by Application
7 Europe
- 7.1 Europe Antibody Drug Conjugate by Country
- 7.1.1 Europe Antibody Drug Conjugate Sales by Country
- 7.1.2 Europe Antibody Drug Conjugate Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Antibody Drug Conjugate Market Facts & Figures by Type
- 7.3 Europe Antibody Drug Conjugate Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Antibody Drug Conjugate by Region
- 8.1.1 Asia Pacific Antibody Drug Conjugate Sales by Region
- 8.1.2 Asia Pacific Antibody Drug Conjugate Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Antibody Drug Conjugate Market Facts & Figures by Type
- 8.3 Asia Pacific Antibody Drug Conjugate Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Antibody Drug Conjugate by Country
- 9.1.1 Latin America Antibody Drug Conjugate Sales by Country
- 9.1.2 Latin America Antibody Drug Conjugate Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Antibody Drug Conjugate Market Facts & Figures by Type
- 9.3 Central & South America Antibody Drug Conjugate Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Antibody Drug Conjugate by Country
- 10.1.1 Middle East and Africa Antibody Drug Conjugate Sales by Country
- 10.1.2 Middle East and Africa Antibody Drug Conjugate Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Antibody Drug Conjugate Market Facts & Figures by Type
- 10.3 Middle East and Africa Antibody Drug Conjugate Market Facts & Figures by Application
11 Company Profiles
- 11.1 Seattle Genetics/Takeda
- 11.1.1 Seattle Genetics/Takeda Corporation Information
- 11.1.2 Seattle Genetics/Takeda Description and Business Overview
- 11.1.3 Seattle Genetics/Takeda Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Seattle Genetics/Takeda Antibody Drug Conjugate Products Offered
- 11.1.5 Seattle Genetics/Takeda Related Developments
- 11.2 Roche
- 11.2.1 Roche Corporation Information
- 11.2.2 Roche Description and Business Overview
- 11.2.3 Roche Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Roche Antibody Drug Conjugate Products Offered
- 11.2.5 Roche Related Developments
- 11.3 ImmunoGen
- 11.3.1 ImmunoGen Corporation Information
- 11.3.2 ImmunoGen Description and Business Overview
- 11.3.3 ImmunoGen Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 ImmunoGen Antibody Drug Conjugate Products Offered
- 11.3.5 ImmunoGen Related Developments
- 11.4 Immunomedics
- 11.4.1 Immunomedics Corporation Information
- 11.4.2 Immunomedics Description and Business Overview
- 11.4.3 Immunomedics Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Immunomedics Antibody Drug Conjugate Products Offered
- 11.4.5 Immunomedics Related Developments
- 11.5 Pfizer
- 11.5.1 Pfizer Corporation Information
- 11.5.2 Pfizer Description and Business Overview
- 11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Pfizer Antibody Drug Conjugate Products Offered
- 11.5.5 Pfizer Related Developments
- 11.6 Celldex Therapeutics
- 11.6.1 Celldex Therapeutics Corporation Information
- 11.6.2 Celldex Therapeutics Description and Business Overview
- 11.6.3 Celldex Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Celldex Therapeutics Antibody Drug Conjugate Products Offered
- 11.6.5 Celldex Therapeutics Related Developments
- 11.7 Millennium Pharmaceuticals
- 11.7.1 Millennium Pharmaceuticals Corporation Information
- 11.7.2 Millennium Pharmaceuticals Description and Business Overview
- 11.7.3 Millennium Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Millennium Pharmaceuticals Antibody Drug Conjugate Products Offered
- 11.7.5 Millennium Pharmaceuticals Related Developments
- 11.8 Bayer HealthCare
- 11.8.1 Bayer HealthCare Corporation Information
- 11.8.2 Bayer HealthCare Description and Business Overview
- 11.8.3 Bayer HealthCare Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Bayer HealthCare Antibody Drug Conjugate Products Offered
- 11.8.5 Bayer HealthCare Related Developments
- 11.9 Mersana Therapeutics
- 11.9.1 Mersana Therapeutics Corporation Information
- 11.9.2 Mersana Therapeutics Description and Business Overview
- 11.9.3 Mersana Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Mersana Therapeutics Antibody Drug Conjugate Products Offered
- 11.9.5 Mersana Therapeutics Related Developments
- 11.10 Heidelberg Pharma
- 11.10.1 Heidelberg Pharma Corporation Information
- 11.10.2 Heidelberg Pharma Description and Business Overview
- 11.10.3 Heidelberg Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Heidelberg Pharma Antibody Drug Conjugate Products Offered
- 11.10.5 Heidelberg Pharma Related Developments
- 11.1 Seattle Genetics/Takeda
- 11.1.1 Seattle Genetics/Takeda Corporation Information
- 11.1.2 Seattle Genetics/Takeda Description and Business Overview
- 11.1.3 Seattle Genetics/Takeda Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Seattle Genetics/Takeda Antibody Drug Conjugate Products Offered
- 11.1.5 Seattle Genetics/Takeda Related Developments
- 11.12 Takeda Pharmaceutical Company Limited
- 11.12.1 Takeda Pharmaceutical Company Limited Corporation Information
- 11.12.2 Takeda Pharmaceutical Company Limited Description and Business Overview
- 11.12.3 Takeda Pharmaceutical Company Limited Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Takeda Pharmaceutical Company Limited Products Offered
- 11.12.5 Takeda Pharmaceutical Company Limited Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Antibody Drug Conjugate Market Estimates and Projections by Region
- 12.1.1 Global Antibody Drug Conjugate Sales Forecast by Regions 2021-2026
- 12.1.2 Global Antibody Drug Conjugate Revenue Forecast by Regions 2021-2026
- 12.2 North America Antibody Drug Conjugate Market Size Forecast (2021-2026)
- 12.2.1 North America: Antibody Drug Conjugate Sales Forecast (2021-2026)
- 12.2.2 North America: Antibody Drug Conjugate Revenue Forecast (2021-2026)
- 12.2.3 North America: Antibody Drug Conjugate Market Size Forecast by Country (2021-2026)
- 12.3 Europe Antibody Drug Conjugate Market Size Forecast (2021-2026)
- 12.3.1 Europe: Antibody Drug Conjugate Sales Forecast (2021-2026)
- 12.3.2 Europe: Antibody Drug Conjugate Revenue Forecast (2021-2026)
- 12.3.3 Europe: Antibody Drug Conjugate Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Antibody Drug Conjugate Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Antibody Drug Conjugate Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Antibody Drug Conjugate Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Antibody Drug Conjugate Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Antibody Drug Conjugate Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Antibody Drug Conjugate Sales Forecast (2021-2026)
- 12.5.2 Latin America: Antibody Drug Conjugate Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Antibody Drug Conjugate Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Antibody Drug Conjugate Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Antibody Drug Conjugate Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Antibody Drug Conjugate Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Antibody Drug Conjugate Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Antibody Drug Conjugate Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Antibody Drug Conjugate Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Antibody Drug Conjugate. Industry analysis & Market Report on Antibody Drug Conjugate is a syndicated market report, published as Global Antibody Drug Conjugate Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Antibody Drug Conjugate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
